English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51931029    Online Users :  1061
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"陳語謙 calvin yu chian chen"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 61-86 of 86  (2 Page(s) Totally)
<< < 1 2 
View [10|25|50] records per page

Institution Date Title Author
中國醫藥大學 2010-08 Structure-Based and Ligand-Based Drug Design for HER 2 Receptor 黃泓縉(Hung-Jin Huang); 李桂仁(Kuei-Jen Lee); 游欣瑋(Hsin Wei Yu); 陳健宇(Chien-Yu Chen); 徐志和(Chih-Ho Hsu); (Hsin-Yi Chen); 蔡輔仁(Fuu-Jen Tsai)*; 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2010-08 Insights into designing the dual-targeted HER2/HSP90 inhibitors 陳建宇(Chien-Yu Chen); 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2010-05 Computational screening and QSAR analysis for design of AMP-activated protein kinase agonist 黃泓縉(Hung-Jin Huang); 陳建宇(Chien-Yu Chen); (Hsin-Yi Chen); 蔡輔仁(Fuu-Jen Tsai)*; 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2010-04 Virtual Screening and Drug Design for PDE-5 Receptor from Traditional Chinese Medicine Database 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2010-03 Chemical engineering in Taiwan in 2007-2009 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2010-03 Bioinformatics, chemoinformatics, and pharmainformatics analysis of HER2/HSP90 dual-targeted inhibitors 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2009-10-17 Reducing without Side Effects A Novel Strategy for Designing the PPAR Agonists (Yea-Huey Chang); (Bau Da Tien); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); (Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2009-10 Ligand-Based Dual Target Drug Design for H1N1: Swine Flu- A Preliminary First Study 陳建宇(Chien-Yu Chen); (Yea-Huey Chang); (Bau Da Tian); 黃泓溍(Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2009-10 Is That Possible to Design the Versatile Inhibitors for H1N1, H5N1, H5N2, and H5N7 陳建宇(Chien-Yu Chen); (Bau Da Tien); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2009-10 Drug Design for the Influenza A Virus Subtype H1N1 陳建宇(Chien-Yu Chen); (Bau Da Tien); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2009-10 Drug Design for KU86 in DNA Break Repair System 陳建宇(Chien-Yu Chen); (Bau Da Tien); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2009-10 A Novel Strategy for Designing Dual-target Inhibitors of KU86 and XRCC4 陳建宇(Chien-Yu Chen); 蔡輔仁(Fuu-Jen Tsai); 鍾景光(Jing-Gung Chung); 蔡長海(Chang-Hai Tsai); 徐媛曼(Yuan-Man Hsu); 黃泓縉(Hung-Jin Huang); 侯庭鏞(Tin-Yun Ho); (Yea-Huey Chang); (Bau Da Tien); 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2009-10 Reducing without Side Effects A Novel Strategy for Designing the PPAR Agonists (Yea-Huey Chang); (Bau Da Tien); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); 黃泓縉(Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2009-10 Drug Design for XRCC4 in Silico 黃泓縉(Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai); 鍾景光(Jing-Gung Chung); 蔡長海(Chang-Hai Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); (Yea-Huey Chang); (Bau Da Tien); 蔡銘修(Ming-Hsui Tsai); 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2009-10 Dual-targeted Drug Design of HER2 and HSP90 by CoMFA Model and Pharmacophore Analysis 黃泓縉(Hung-Jin Huang); (Bau Da Tien); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2009-10 What is the Key Point for Designing HER2 Inhibitors 黃泓縉(Hung-Jin Huang); (Bau Da Tien); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2009-10 Drug Design for AMP-Activated Protein Kinase Agonists in Silico 陳建宇(Chien-Yu Chen); (Bau Da Tien); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2009-10 Could Traditional Chinese Medicine Used for Curing Erectile Dysfunction 陳建宇(Chien-Yu Chen); (Bau Da Tien); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2009-08 Discovery of potent inhibitors for phosphodiesterase 5 by virtual screening and pharmacophore analysis 陳建宇(Chien-yu CHEN); (Yea-huey CHANG); (Bau Da Tian); 黃泓縉(Hung-jin HUANG); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai); 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2009-03 Pharmacoinformatics approach for mPGES-1 in anti-inflammation by 3D-QSAR pharmacophore mapping 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2009-01 De novo design of novel selective COX-2 inhibitors: from virtual screening to pharmacophore analysis 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2009-01 Chemoinformatics and pharmacoinformatics approach for exploring the GABA-A agonist from Chinese herb suanzaoren 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2008-11 Insights into the suanzaoren mechanism—From constructing the 3D structure of GABA-A receptor to its binding interaction analysis 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2008-11 Discovery of Novel Inhibitors for c-Met by Virtual Screening and Pharmacophore Analysis 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2008-09 Inhibiting the Vascular Smooth Muscle Cells Proliferation by EPC and DPPC Liposomes Encapsulated Magnolol 陳語謙(Calvin Yu-Chian Chen)*
中國醫藥大學 2008-07 A Novel Perspective on Designing the Inhibitor of HER2 Receptor 陳語謙(Calvin Yu-Chian Chen)*

Showing items 61-86 of 86  (2 Page(s) Totally)
<< < 1 2 
View [10|25|50] records per page